ARCHIVES

NCI Cancer Bulletin publicized board’s resignation over liability concerns.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

Letter to the Editor

February 21, 2003

Also in this 8-page issue: Dept. of Justice, Congress to investigate Merck and FDA actions on Vioxx; FDA asks IOM to study its monitoring system for approved drugs.

November 12, 2004

NCA Urges Pay Line Adjustment To Cut Back On Grant Duplications

October 10, 1980

Unclear Whether Clinical Trials Benefit Patients, Review Finds

February 27, 2004

Panel Angered By Unreasonable Senate Committee Demands, Will Seek Meeting With Hatch On Probe

April 24, 1981

Radiotherapy Wing Contractor Dropped

March 27, 1981